Contacts: Anthony G. Viscogliosi, (212) 583-9700 ext. 100
Nick Kilsby, Creative Partners PR, (203) 705-9202


NEW YORK, NY- September 17, 2007 - Small Bone Innovations, Inc. (SBi), a single source provider of products, technology and education for treating small bones and joints, reports that more than 1,000 hand surgeons have registered to attend eight workshops funded by SBi during the 62nd Annual Meeting of the American Society for Surgery of the Hand (ASSH) to be held in Seattle from September 26 through September 29, 2007.

The conference in Seattle’s Washington State Convention & Trade Center is expected to attract more than 2,000 surgeons and several thousand orthopedics industry representatives from 36 nations involved in the treatment of the millions who annually, due to accidents, birth defects or diseases such as arthritis, require treatment in the upper limbs.

“For people like me, the ASSH conference is an opportunity to present ‘first hand’ our latest technology and give surgeons the chance to practice a variety of procedures under the guidance of some of the nation’s best known hand surgeons,” said Anthony G. Viscogliosi, Chairman and CEO of SBi. “Although this is only our third ASSH convention, we are honored to be the exclusive ‘Platinum’ sponsor of the event - especially the workshops for which more than half of all surgeons attending have registered – in addition to having SBi products featured in many of the CME (continuing medical education) sessions,” he added.

SBi will also host a meeting of the ASSH Young Leaders Group that comprises 60 surgeons selected by the society to work together and share experiences in the advancement of hand surgery. The group’s meetings have been supported by SBi since inception in 2005.

SBi is launching ten new products at ASSH to augment its Elbow Management System; Artelon© spacer suite for treating osteoarthritis in the thumb; the SBi Wrist portfolio; and its ‘FIX’ range of foot & ankle fixation and arthroplasty products. The new products are central to SBi’s goal of developing the industry’s widest and deepest, anatomically focused portfolio.

According to SBi, out of more than 460 ‘podium talks’ at the ASSH convention, 126 will address arthroplasty, tissue technology and trauma of which 49 will be based on the use of SBi devices. The company will also be responsible for four poster exhibits at the event.

The dates, content and faculty of the eight workshops sponsored by SBi are as follows:

Wednesday, September 26, 2007 5:00 – 6:00 PM

Fixed Angle and Fracture Specific Plating for Simple to Complex Distal Radius Fractures

Jesse B. Jupiter, MD, Boston, MA
David C. Ring, MD, Boston, MA

Three innovative different distal radius systems will be presented, highlighting the strengths of each for treating various simple and complex fracture patterns including low profile variable angle locking distal volar plating, fixed angle distal volar and dorsal plating, and fragment specific plating solutions.

Presenting a Surgical Implant Algorithmic Approach for Osteoarthritis of the CMC Joint
Alejandro Badia, MD, Miami, FL

Osteoarthritis of the CMC joint can be treated in a number of ways. The faculty will present an algorithmic approach for treating the osteoarthritic joint with various implant options based on disease stage including early results and technique of Arthroscopic interpositional spacers and long term results of total joint replacement.

Thursday, September 27, 2007 11:45 AM – 12:45 PM

New Instrumentation for a Minimal Resection Anatomic Total Wrist
William P. Cooney, MD, Vero Beach, FL
Amit Gupta, MD, Louisville, KY

Reproducible positive results with total wrist arthroplasty rely heavily on the instrumentation and surgical technique. An anatomic wrist instrumentation system (and implant) will be presented, focusing on minimal bone resection and consistent results. Medium Term results of the SBi Total Wrist Arthroplasty system will be reviewed along with discussion on the ongoing Wrist Registry.

Treatment of Thumb CMC Arthritis

Sanjay S. Desai, MD, Richmond, VA
Randall W. Culp, MD, King of Prussia, PA

A number of different methods can be successfully used for treatment of osteoarthritis of the CMC joint. This workshop will focus on strategies for the use of a minimally invasive approach to treat earlier stage OA utilizing a biodegradable resurfacing implant including medium term outcome analysis.

Friday, September 28, 2007 11:45 AM – 12:45 PM

Solution to DRUJ Pain, Repair vs. Remove
Sanjay S. Desai, MD, Richmond, VA
Richard A. Berger, MD, PhD, Rochester, MN

Sigmoid Notch prosthesis, in conjunction with ulnar head replacement, offers an anatomic solution for the restoration of kinematics and stability for primary DRUJ treatment and salvage. This presentation will explore the early outcomes of a true anatomic total DRUJ replacement.

Surgical Technique and Short Term Results for the Radio Capitellum Resurfacing Procedure
William P. Cooney, MD, Vero Beach, FL

The SBi Uni-Elbow™ Radio Capitellum System is designed specifically for uni-compartmental arthroplasty for degenerative joint diseases, the correction of functional deformities, revision procedures and treatment of fractures. This presentation will discuss the indications, implantation and early results of the first uni-compartmental elbow replacement system.

Saturday, September 29, 2007 6:45 AM – 7:45 AM

Radial Head Fractures, ORIF vs Radial Head Implant Arthoplasty
Douglas P. Hanel, MD, Seattle, WA
Nader Paksima, DO, MPH, New York, NY

Various technologies and techniques for treating radial head fractures will be presented in an algorithmic approach. This workshop will review the signs of a salvageable radial head and that of a necessary replacement. A complete elbow management system will be explored that offers a complete set of solutions for elbow trauma.

Long Term Outcomes of PIP/MCP Arthroplasty
Kevin J. Renfree, MD, Phoenix, AZ
Peter M. Murray, MD, Jacksonville, FL

Proximal Interphalangeal/Metacarpalphalangeal joint arthroplasty is known to be an effective method of relieving pain while preserving motion in the damaged joints. The PIP and MCP joints can be successfully replaced with a variety of implants and approaches including dorsal, lateral and palmar.

For a detailed schedule of workshops or for more information on the ASSH conference, please visit:

About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Bros., LLC, (VB), the New York-based merchant banking firm that specializes in the musculoskeletal/orthopedic sector. VB created SBi as the first company to focus purely on small bone & joint science. By integrating established companies and professionals in the field, SBi can offer a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints. Today, SBi has more than 140 employees at facilities in New York, NY, Morrisville, PA and Minneapolis, MN.

SBi closed on the sale of $42.2 million of its securities in December 2005. At the time, based on data provided by Venture Source, this was the largest venture capital investment ever recorded in the field of orthopedic devices..

SBi was a 2006 recipient of Red Herring magazine’s annual “Red Herring 100 North America” award, recognizing SBi as one of the nation’s leading technology companies and the only orthopedic device company selected among an initial entry of more than one thousand firms.
Additionally, SBi’s Artelon® CMC-I Spacer, developed for patients with osteoarthritis at the base of the thumb, was featured on the cover and highlighted within Medical Design Technology magazine’s “Year of Innovation” issue as one of the most fascinating technologies influencing the medical device industry.

Medical Device & Diagnostic Industry magazine named SBi to its list of “50 Companies to Watch” in 2006, noting, “Small Bone Innovations is going against the grain in its determination to become a market leader in the small bone & joint device sector.”

For more information on SBi, please visit:

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.
Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of nearly half a century of experience analyzing and investing in the musculoskeletal/orthopedics sector, directing literally billions of dollars through the orthopedics industry.  They have pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.

Forward-looking statements
This press release may contain forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.

> Back to Press Releases


Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.